Search for other papers by Shatha Alharazy in
Google Scholar
PubMed
Search for other papers by M Denise Robertson in
Google Scholar
PubMed
Search for other papers by Susan Lanham-New in
Google Scholar
PubMed
Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
Search for other papers by Muhammad Imran Naseer in
Google Scholar
PubMed
Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
Centre for Innovation in Personalized Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
Search for other papers by Adeel G Chaudhary in
Google Scholar
PubMed
Search for other papers by Eman Alissa in
Google Scholar
PubMed
.41) *Significant correlation ( P < 0.05). 25(OH)D, 25-hydroxyvitamin D; BMI, body mass index; Ca, calcium; PO 4 , phosphate; PTH is parathyroid hormone. Total 25(OH)D and free 25(OH)D associations with skin tone, veiling type, parity, and sun
Search for other papers by Johanna Öberg in
Google Scholar
PubMed
Search for other papers by Rolf Jorde in
Google Scholar
PubMed
Diagnostic Clinic, University Hospital of North Norway, Tromso, Norway
Search for other papers by Yngve Figenschau in
Google Scholar
PubMed
Search for other papers by Per Medbøe Thorsby in
Google Scholar
PubMed
Search for other papers by Sandra Rinne Dahl in
Google Scholar
PubMed
Search for other papers by Anne Winther in
Google Scholar
PubMed
Division of Internal Medicine, University Hospital of North Norway, Tromso, Norway
Search for other papers by Guri Grimnes in
Google Scholar
PubMed
+, combined hormonal contraceptive users; DBP, vitamin D-binding protein; free 25(OH)D , measured free 25(OH)D; FGF23, fibroblast growth factor; PTH, parathyroid hormone; VMR, 24,25(OH) 2 D/25(OH)D vitamin D metabolite ratio; 2325(OH)D, 25-hydroxyvitamin D; 1,25
Search for other papers by Göran Oleröd in
Google Scholar
PubMed
Search for other papers by Lillemor Mattsson Hultén in
Google Scholar
PubMed
Search for other papers by Ola Hammarsten in
Google Scholar
PubMed
Search for other papers by Eva Klingberg in
Google Scholar
PubMed
Kowalski MA Ryzen E Haddad JG. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein . Journal of Clinical Endocrinology and Metabolism 1986 63 954 – 959 . ( doi:10
Department of Clinical Chemistry, Hematology and Immunology, Noordwest Ziekenhuis, Alkmaar, The Netherlands
Search for other papers by Niek F Dirks in
Google Scholar
PubMed
Search for other papers by Etienne Cavalier in
Google Scholar
PubMed
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed
-hydroxyvitamin D Over 85% of 25(OH)D and 1,25(OH) 2 D is bound to VDBP, while most of the remaining are bound to albumin and only about 0.03% circulates free of any binding protein ( 21 ). Some have suggested that calculated bioavailable 25(OH)D (not bound to
Birmingham Women’s Foundation Hospital, Edgbaston, Birmingham, UK
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Search for other papers by J A Tamblyn in
Google Scholar
PubMed
Search for other papers by C Jenkinson in
Google Scholar
PubMed
Search for other papers by D P Larner in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Search for other papers by M Hewison in
Google Scholar
PubMed
Birmingham Women’s Foundation Hospital, Edgbaston, Birmingham, UK
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Search for other papers by M D Kilby in
Google Scholar
PubMed
major site for vitamin D metabolism, expressing the 25-hydroxyvitamin D3 1α-hydroxylase (1α-hydroxylase) enzyme that synthesises 1,25-dihydroxyvitamin D3 (1,25(OH) 2 D3) from precursor 25-hydroxyvitamin D3 (25(OH)D3), as well as 25-hydroxyvitamin D-24
School of Nursing, Institute of Clinical Sciences, University of Birmingham, Edgbaston, Birmingham, UK
Search for other papers by Jane Fletcher in
Google Scholar
PubMed
Search for other papers by Emma L Bishop in
Google Scholar
PubMed
Search for other papers by Stephanie R Harrison in
Google Scholar
PubMed
Search for other papers by Amelia Swift in
Google Scholar
PubMed
Search for other papers by Sheldon C Cooper in
Google Scholar
PubMed
Search for other papers by Sarah K Dimeloe in
Google Scholar
PubMed
Search for other papers by Karim Raza in
Google Scholar
PubMed
Search for other papers by Martin Hewison in
Google Scholar
PubMed
outlined in Fig. 1 , the physiological actions of vitamin D metabolites are dependent on further metabolic steps ( 1 ). The first occurs in the liver via the enzyme vitamin D-25-hydroxylase (25-OHase) to generate 25-hydroxyvitamin D (25D). While this is
Search for other papers by Zhen-yu Song in
Google Scholar
PubMed
Search for other papers by Qiuming Yao in
Google Scholar
PubMed
Search for other papers by Zhiyuan Zhuo in
Google Scholar
PubMed
Search for other papers by Zhe Ma in
Google Scholar
PubMed
Search for other papers by Gang Chen in
Google Scholar
PubMed
useful treatment measures are urgently needed by people to improve the survival rate of prostate cancer patients. The major circulating form of vitamin D in human body is 25-hydroxyvitamin D (25(OH)D), which comes from vitamin D via 25-hydroxylation
Search for other papers by Barbara J Boucher in
Google Scholar
PubMed
analyses. Free vs bound 25-hydroxyvitamin D Most 25(OH)D in the circulation is bound to the binding proteins already mentioned but small amounts remain unbound or ‘free’. The relative importance of unbound versus bound 25(OH)D uptake by different
Search for other papers by Behnaz Abiri in
Google Scholar
PubMed
Search for other papers by Majid Valizadeh in
Google Scholar
PubMed
Search for other papers by Amirhossein Ramezani Ahmadi in
Google Scholar
PubMed
Search for other papers by Shirin Amini in
Google Scholar
PubMed
Search for other papers by Mohammad Nikoohemmat in
Google Scholar
PubMed
Search for other papers by Faeze Abbaspour in
Google Scholar
PubMed
Search for other papers by Farhad Hosseinpanah in
Google Scholar
PubMed
2021 75 e14718 . ( https://doi.org/10.1111/ijcp.14718 ) 50 Saarnio E Pekkinen M Itkonen ST Kemi V Karp H Ivaska KK Risteli J Koivula MK Kärkkäinen M Mäkitie O , et al. Low free 25-hydroxyvitamin D and high vitamin D binding
Search for other papers by Stefan Pilz in
Google Scholar
PubMed
Search for other papers by Armin Zittermann in
Google Scholar
PubMed
Search for other papers by Christian Trummer in
Google Scholar
PubMed
Search for other papers by Verena Theiler-Schwetz in
Google Scholar
PubMed
Search for other papers by Elisabeth Lerchbaum in
Google Scholar
PubMed
Search for other papers by Martin H Keppel in
Google Scholar
PubMed
Search for other papers by Martin R Grübler in
Google Scholar
PubMed
Medical Clinic V (Nephrology, Hypertensiology, Rheumatology, Endocrinology, Diabetology), Medical Faculty Mannheim, Ruperto-Carola University of Heidelberg, Heidelberg, Germany
Synlab Medical Center of Human Genetics Mannheim, Mannheim, Germany
Search for other papers by Winfried März in
Google Scholar
PubMed
Search for other papers by Marlene Pandis in
Google Scholar
PubMed
Lerchbaum E Pieber TR Obermayer-Pietsch B Wilhelm M Hahn A , et al . Hormonal contraceptive use is associated With higher total but unaltered free 25-hydroxyvitamin D serum concentrations . Journal of Clinical Endocrinology and Metabolism 2018 103